These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6465132)

  • 1. Disappearance of microspherocytes in peripheral circulation and normalization of decreased lipids in plasma and in red cells of patients with hereditary spherocytosis after splenectomy.
    Sugihara T; Miyashima K; Yawata Y
    Am J Hematol; 1984 Aug; 17(2):129-39. PubMed ID: 6465132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Observations on plasma and red cell lipids in hereditary spherocytosis.
    Sugihara T; Yawata Y
    Clin Chim Acta; 1984 Feb; 137(2):227-32. PubMed ID: 6705235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Contribution of the spleen to the lipid metabolism in plasma and red cells. On hereditary spherocytosis and hereditary high red cell membrane phosphatidylcholine hemolytic anemia].
    Sugihara T; Otsuka A; Yawata Y
    Rinsho Ketsueki; 1989 Aug; 30(8):1248-55. PubMed ID: 2601042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma and erythrocyte lipids in hereditary spherocytosis.
    Johnsson R; Saris NE
    Clin Chim Acta; 1981 Aug; 114(2-3):263-8. PubMed ID: 7285349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Membrane lipid depletion in hyperpermeable red blood cells: its role in the genesis of spherocytes in hereditary spherocytosis.
    Jacob HS
    J Clin Invest; 1967 Dec; 46(12):2083-94. PubMed ID: 6074008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of membrane lipids in the survival of red cells in hereditary spherocytosis.
    Cooper RA; Jandl JH
    J Clin Invest; 1969 Apr; 48(4):736-44. PubMed ID: 5774111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased calcium uptake in the red cells of unsplenectomized patients with hereditary spherocytosis: significant contribution of reticulocytosis.
    Shimoda M; Miyashima K; Yawata Y
    Clin Chim Acta; 1984 Sep; 142(2):183-92. PubMed ID: 6499204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Red cell membrane proteins and lipids in spherocytosis.
    Johnsson R
    Scand J Haematol; 1978 Apr; 20(4):341-50. PubMed ID: 653313
    [No Abstract]   [Full Text] [Related]  

  • 9. Temporal differences in membrane loss lead to distinct reticulocyte features in hereditary spherocytosis and in immune hemolytic anemia.
    Da Costa L; Mohandas N; Sorette M; Grange MJ; Tchernia G; Cynober T
    Blood; 2001 Nov; 98(10):2894-9. PubMed ID: 11698268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of splenectomy in hereditary spherocytosis by dual angle laser light cytometry.
    Ricard MP; Gilsanz F
    Clin Lab Haematol; 1996 Dec; 18(4):249-51. PubMed ID: 9054697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The selective and conjoint loss of red cell lipids.
    Cooper RA; Jandl JH
    J Clin Invest; 1969 May; 48(5):906-14. PubMed ID: 5780200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Measurement of phospholipids in erythrocytes, plasma and platelets in a patient with hereditary spherocytosis].
    César JM; Fernández I; Navarro JL
    Sangre (Barc); 1989 Aug; 34(4):300-2. PubMed ID: 2772783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent progress in research on red cell membrane disorders in Japan: pathogenesis of microspherocytosis in hereditary spherocytosis, sodium transport abnormalities in stomatocytosis, and homeo-adaptive compensatory mechanism for membrane fluidity in red cell membrane lipid abnormalities.
    Yawata Y
    Nihon Ketsueki Gakkai Zasshi; 1983 Dec; 46(7):1426-40. PubMed ID: 6675403
    [No Abstract]   [Full Text] [Related]  

  • 14. Heinz body formation in red cell membrane disorders: its acceleration in membrane lipid abnormalities.
    Mannoji M; Sugihra T; Yawata Y
    Scand J Haematol; 1985 Sep; 35(3):257-63. PubMed ID: 4059856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of splenectomy on serum lipids and experimental atherosclerosis.
    Asai K; Kuzuya M; Naito M; Funaki C; Kuzuya F
    Angiology; 1988 Jun; 39(6):497-504. PubMed ID: 3377269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of spleen in hereditary spherocytosis: evidence for increased in vitro proteolysis of red cell membrane.
    De Matteis MC; De Angelis V; Sorrentino F; Bonollo E; Vettore L
    Br J Haematol; 1991 Sep; 79(1):108-12. PubMed ID: 1911366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Embolisation of the splenic artery as an alternative to splenectomy for treating hereditary spherocytosis.
    Hołowiecki J; Jarczok K; Wawrzynek Z
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(6):913-6. PubMed ID: 6200404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spectrin oligomers of the red cell membrane extracts in hereditary spherocytosis.
    Marík T; Kodícek M; Brabec V
    Biomed Biochim Acta; 1983; 42(11-12):S32-7. PubMed ID: 6675711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Traditional laboratory measures of cardiovascular risk in hereditary spherocytosis.
    Crary SE; Troendle S; Ahmad N; Buchanan GR
    Pediatr Blood Cancer; 2010 Oct; 55(4):684-9. PubMed ID: 20589636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Red cell life span after splenectomy in hereditary spherocytosis.
    Chapman RG; McDonald LL
    J Clin Invest; 1968 Oct; 47(10):2263-7. PubMed ID: 5676521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.